COVID-19

COVID-19 vaccination site at One Hundred Oaks to close April 7

Crowe’s research honored

Vanderbilt’s James Crowe Jr., MD, was among those to receive 2023 Advocacy Awards from Research!America at the biomedical research advocacy organization’s annual awards program in Washington, D.C.

Study finds RSV may evade vaccines via rapid mutation

A Vanderbilt study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading.

COVID-19 battle begins in the nose

A high upper airway concentration of the virus that causes COVID-19 was associated with changes in gene expression that could impact disease progression, Vanderbilt researchers discovered.

Study to explore COVID’s impact on essential workers

Vanderbilt researchers are inviting non-health care essential workers to participate in a study to better understand how they continue to be impacted by COVID-19.

Emerging Infections Program lands national award for COVID response

Vanderbilt’s Emerging Infections Program (EIP) recently received the Toby Merlin Award for Excellence in Emergency Response, presented by the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry.

1 2 3 4 5 38